SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-004667
Filing Date
2022-02-28
Accepted
2022-02-28 17:15:56
Documents
1
Period of Report
2022-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3555
  Complete submission text file 0001437749-22-004667.txt   4960
Mailing Address 22026 20TH AVENUE S E SUITE 102 BOTHELL WA 98021
Business Address
QUAY STEVEN C (Reporting) CIK: 0001008227 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35610 | Film No.: 22691416

Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Issuer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations